Brief: GT Biopharma Announces $3.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
May 21 (Reuters) - GT Biopharma Inc GTBP.O :
* GT BIOPHARMA, INC. ANNOUNCES $3.2 MILLION REGISTERED
DIRECT
OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES
Source text for Eikon: ID:nGNX3kY1l9
Further company coverage: GTBP.O
((Reuters.Briefs@thomsonreuters.com;))